Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Scale-Up Processes

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...

Bioreactor Design and Operational System

Bioreactor Design and Operational System

Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Bioreactor Controls-III

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...

Designing Growth Media for Bioreactors

Designing Growth Media for Bioreactors

Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...

Bioreactor Controls-I

Bioreactor Controls-I

Maintaining optimal conditions within fermenters is essential for maximizing microbial productivity and ensuring process efficiency. This lesson focuses on key parameters—temperature, foam, pH, carbon dioxide, oxygen, and pressure—and their precise measurement and control strategies in fermentation systems.Temperature ControlTemperature regulation is critical due to the exothermic nature of many fermentation processes. In small laboratory fermenters, temperature is commonly monitored using...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

Nature cancer·2026

Same author

From feedback to action: a process evaluation of implementation strategies for sepsis bundles in emergency departments.

Frontiers in medicine·2026

Same author

Formative Evaluation to Inform Implementation of Sepsis Bundles in Emergency Departments.

Annals of emergency medicine·2025

Same author

Vaccine process technology-A decade of progress.

Biotechnology and bioengineering·2024

Same author

Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia.

Molecular therapy. Methods & clinical development·2023

Same author

Assessment of implementation methods in sepsis: study protocol for a cluster-randomized hybrid type 2 trial.

Trials·2023

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Design-for-Six-Sigma To Develop a Bioprocess Knowledge Management Framework.

Beth Junker¹, Gargi Maheshwari, Todd Ranheim

¹Biologics Discovery, Bioprocess Development, Biologics Manufacturing Science & Commercialization, Merck Research Laboratories Information Technology, Merck and Co, Inc.

PDA Journal of Pharmaceutical Science and Technology

|April 20, 2011

Summary

This summary is machine-generated.

A new knowledge management strategy, using Design-for-Six-Sigma (DFSS), streamlines biopharmaceutical development. This approach enhances productivity and resource efficiency by leveraging existing knowledge and customer input for better outcomes.

More Related Videos

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Jun 2, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

Area of Science:

Biopharmaceutical industry
Knowledge management
Process optimization

Background:

High costs in biopharmaceutical development necessitate increased productivity and flexibility.
Knowledge reuse is a key strategy for streamlining operations and improving competitiveness.
Existing knowledge management practices require optimization for efficiency and effectiveness.

Purpose of the Study:

To develop a knowledge management (KM) strategy for bioprocess-related information.
To support quality-by-design and process validation for biopharmaceutical products.
To enhance organizational productivity and resource utilization through efficient knowledge reuse.

Main Methods:

A Design-for-Six-Sigma (DFSS) approach was employed for its streamlined and efficient methodology.
The KM strategy was structured into nine workstreams, derived from solution buckets and individual tasks.
Evaluation involved assessing workstream designs against best practices, project charter, and design inputs, with risk mitigation.

Main Results:

A robust KM strategy was developed, minimizing resource requirements for team leaders and members.
The strategy incorporated customer (staff) input for selecting appropriate solutions to knowledge-based challenges.
Resource and timing estimates were generated for management sponsorship, leveraging existing IT and governance structures.

Conclusions:

The implemented KM strategy supports quality-by-design and process validation in biopharmaceutical development.
The DFSS-based approach proved efficient, minimizing resource allocation.
Selected metrics will track the success of pilots and full implementation of the KM strategy.